InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
T+90 hit rate
23%
T+90 mean return
-14.0%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Bhavnagri Veer, Conseiller Général. Insider active across 2 companies, notably Allogene Therapeutics, Inc.. Cumulatively, 18 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €140k. History available since 17 May 2021. The latest transaction was filed on 14 March 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations18 total
23,628 shares@ US$5.6737.7% of flowCommon StockSEC:0001593968-23-000491:0
3,000 shares@ US$6.855.8% of flowCommon StockSEC:0001593968-23-000317:0
3,000 shares@ US$7.045.9% of flowCommon StockSEC:0001593968-23-000168:0
5,602 shares@ US$7.530611.9% of flowCommon StockSEC:0001593968-22-001742:0
175,438 shares0Common StockSEC:0001214659-22-004370:0
8,849 shares@ US$7.68020.0090% mcap48.4% of flowCommon StockSEC:0001214659-22-004086:0
5,000 shares@ US$2.2720.2% of flowCommon StockSEC:0001214659-21-009625
5,000 shares@ US$2.270.0014% mcap7.5% of flowCommon StockSEC:0001214659-21-009625:0
5,000 shares@ US$2.270.0014% mcap7.5% of flowCommon StockSEC:0001214659-21-008761:0
5,000 shares@ US$2.2720.3% of flowCommon StockSEC:0001214659-21-008761
5,000 shares@ US$2.2720.2% of flowCommon StockSEC:0001214659-21-007588
5,000 shares@ US$2.270.0014% mcap7.5% of flowCommon StockSEC:0001214659-21-007588:0
5,000 shares@ US$2.270.0014% mcap7.3% of flowCommon StockSEC:0001214659-21-006631:0
5,000 shares@ US$2.2719.7% of flowCommon StockSEC:0001214659-21-006631
5,000 shares@ US$2.2719.6% of flowCommon StockSEC:0001214659-21-005767
5,000 shares@ US$2.270.0013% mcap7.2% of flowCommon StockSEC:0001214659-21-005767:0
5,000 shares@ US$2.270.0014% mcap7.3% of flowCommon StockSEC:0001214659-21-005621:0
5,000 shares@ US$2.277.3% of flowCommon StockSEC:0001214659-21-005621
18 of 18 declarations
About Bhavnagri Veer
Veer Bhavnagri is General Counsel at Allogene Therapeutics, Inc. He is responsible for the company's legal affairs and compliance. Veer plays a key role in managing legal risks and protecting the company's interests. His expertise in business law is essential for navigating the complex regulatory landscape of the industry.
